| scholarly article | Q13442814 |
| P50 | author | Xingwang Zhang | Q56992009 |
| P2093 | author name string | Yue Zhao | |
| Zhiguo Ma | |||
| Huijie Xing | |||
| P2860 | cites work | Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique | Q83926698 |
| Enhancement of griseofulvin release from liquisolid compacts | Q84775761 | ||
| Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization | Q84991817 | ||
| Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres | Q85395103 | ||
| Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib | Q86125318 | ||
| [Enhancing of drug bioavailability using liquisolid system formulation] | Q86242816 | ||
| Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions | Q86828647 | ||
| Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment | Q87303622 | ||
| Preparation and characterization of fast dissolving flurbiprofen and esomeprazole solid dispersion using spray drying technique | Q87337707 | ||
| Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen | Q87413760 | ||
| Physicochemical characterization and dissolution studies of acyclovir solid dispersions with Pluronic F127 prepared by the kneading method | Q87426469 | ||
| Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants | Q87534468 | ||
| Preparation and pharmaceutical evaluation of new tacrolimus-loaded solid self-emulsifying drug delivery system | Q87610098 | ||
| Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation | Q87611453 | ||
| Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles | Q87811658 | ||
| Preparation of ultra-fine powders from polysaccharide-coated solid lipid nanoparticles and nanostructured lipid carriers by innovative nano spray drying technology | Q87856593 | ||
| Dissolution and precipitation behavior of ternary solid dispersions of ezetimibe in biorelevant media | Q88052201 | ||
| Microemulsion Transdermal Formulation for Simultaneous Delivery of Valsartan and Nifedipine: Formulation by Design | Q88786966 | ||
| Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus | Q89215046 | ||
| Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study | Q89795073 | ||
| Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery | Q94705201 | ||
| EVALUATION OF SORPTIVE PROPERTIES OF VARIOUS CARRIERS AND COATING MATERIALS FOR LIQUISOLID SYSTEMS | Q95512353 | ||
| Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions | Q95812582 | ||
| Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration | Q48736858 | ||
| Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting | Q48758897 | ||
| Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential. | Q48906792 | ||
| In-vitro digestion of curcumin loaded chitosan-coated liposomes. | Q49568764 | ||
| Development of a New Aprepitant Liquisolid Formulation with the Aid of Artificial Neural Networks and Genetic Programming | Q49588516 | ||
| Development of a carboxymethyl chitosan functionalized nanoemulsion formulation for increasing aqueous solubility, stability and skin permeability of astaxanthin using low-energy method | Q49991071 | ||
| Characterization of the Dissolution Behavior of Piperine/Cyclodextrins Inclusion Complexes | Q50086536 | ||
| Zeta potential changing self-emulsifying drug delivery systems containing phosphorylated polysaccharides | Q50197364 | ||
| Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: Physicochemical characterization and in vivo evaluation | Q50268466 | ||
| Optimization of olive oil based O/W nanoemulsions prepared through ultrasonic homogenization: A response surface methodology approach. | Q50753241 | ||
| Nanoemulsions Containing a Coumarin-Rich Extract from Pterocaulon balansae (Asteraceae) for the Treatment of Ocular Acanthamoeba Keratitis. | Q50849539 | ||
| Formulation, Characterization and Properties of Hemp Seed Oil and Its Emulsions. | Q50899681 | ||
| Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems. | Q50909677 | ||
| Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis. | Q51111744 | ||
| Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate. | Q51289561 | ||
| Development of micro-fibrous solid dispersions of poorly water-soluble drugs in sucrose using temperature-controlled centrifugal spinning | Q27311607 | ||
| A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability | Q28293773 | ||
| Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development | Q28468556 | ||
| Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique | Q28821517 | ||
| Rapid disintegrating tablets of simvastatin dispersions in polyoxyethylene-polypropylene block copolymer for maximized disintegration and dissolution | Q28822355 | ||
| Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations | Q30390764 | ||
| Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing. | Q31043970 | ||
| Solid dispersions of efonidipine hydrochloride ethanolate with improved physicochemical and pharmacokinetic properties prepared with microwave treatment | Q31123177 | ||
| Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights. | Q31150575 | ||
| Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. | Q33529836 | ||
| Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles | Q33683206 | ||
| Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins. | Q33803717 | ||
| Liposomal Formulations in Clinical Use: An Updated Review. | Q33850427 | ||
| Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. | Q33935309 | ||
| Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan | Q34413196 | ||
| Biotinylated liposomes as potential carriers for the oral delivery of insulin. | Q34869982 | ||
| Physico-chemical stability of colloidal lipid particles | Q35174531 | ||
| Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers | Q35596460 | ||
| Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs | Q35744968 | ||
| Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug. | Q35851242 | ||
| Amorphous solid dispersions: Rational selection of a manufacturing process | Q35908887 | ||
| Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement | Q35924348 | ||
| Design, optimization and evaluation of glipizide solid self-nanoemulsifying drug delivery for enhanced solubility and dissolution | Q36162058 | ||
| Two novel cocrystals of lamotrigine with isomeric bipyridines and in situ monitoring of the cocrystallization. | Q36394409 | ||
| Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor(®) El-Based Liquisolid Tablets | Q36509478 | ||
| Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs | Q36748145 | ||
| Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study | Q36870135 | ||
| Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. | Q36949647 | ||
| Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs | Q37025634 | ||
| Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective | Q37031077 | ||
| Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers | Q37053563 | ||
| Low-viscosity hydroxypropylcellulose (HPC) grades SL and SSL: versatile pharmaceutical polymers for dissolution enhancement, controlled release, and pharmaceutical processing | Q41988089 | ||
| Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release | Q41988444 | ||
| Improved Oral Bioavailability and Liver Targeting of Sorafenib Solid Lipid Nanoparticles in Rats | Q41990552 | ||
| Enhancement of dissolution rate of indomethacin: using liquisolid compacts | Q42281281 | ||
| Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability | Q42291604 | ||
| Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets. | Q42719133 | ||
| Formulation and evaluation of liquisolid compacts for olmesartan medoxomil | Q42920272 | ||
| Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design | Q42975655 | ||
| Preparation and characterization of solid dispersion of simvastatin | Q43025612 | ||
| Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation. | Q43102553 | ||
| Effervescence Assisted Fusion Technique to Enhance the Solubility of Drugs | Q43147086 | ||
| Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion | Q43636178 | ||
| Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles. | Q43948391 | ||
| Glass formation in barbiturates and solid dispersion systems of barbiturates with citric acid | Q44061700 | ||
| HPMC as a potential enhancer of nimodipine biopharmaceutical properties via ball-milled solid dispersions. | Q44361032 | ||
| Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers | Q44752621 | ||
| Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process | Q45082005 | ||
| Transparent dispersions of milk-fat-based nanostructured lipid carriers for delivery of β-carotene | Q45158081 | ||
| Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying | Q45164887 | ||
| Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. | Q45918635 | ||
| Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. | Q46080514 | ||
| Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives | Q46185895 | ||
| Liquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage forms | Q46223241 | ||
| Antioxidant and hepatoprotective effects of silymarin phytosomes compared to milk thistle extract in CCl4 induced hepatotoxicity in rats. | Q46228796 | ||
| Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation | Q46337926 | ||
| Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts | Q46424028 | ||
| Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices | Q46468524 | ||
| Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique | Q46596588 | ||
| Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol | Q46637178 | ||
| Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate | Q46826022 | ||
| Suitability of various excipients as carrier and coating materials for liquisolid compacts | Q46868488 | ||
| Size-Dependent Translocation of Nanoemulsions via Oral Delivery | Q47206101 | ||
| Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer | Q47210498 | ||
| Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions. | Q47324119 | ||
| Application of hot melt extrusion for improving bioavailability of artemisinin a thermolabile drug | Q47341232 | ||
| Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model | Q47682832 | ||
| Improvement in the water solubility of drugs with a solid dispersion system by spray drying and hot-melt extrusion with using the amphiphilic polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer and d-mannitol | Q47688026 | ||
| Development of self-microemulsifying drug delivery system for oral delivery of poorly water-soluble nutraceuticals. | Q47749909 | ||
| A dabigatran etexilate phospholipid complex nanoemulsion system for further oral bioavailability by reducing drug-leakage in the gastrointestinal tract | Q47752649 | ||
| Lipid nanoparticles for the delivery of active natural medicines | Q47776131 | ||
| Efficient production of solid dispersions by spray drying solutions of high solid content using a 3-fluid nozzle | Q47786941 | ||
| Two-phase amorphous-amorphous solid drug dispersion with enhanced stability, solubility and bioavailability resulting from ultrasonic dispersion of an immiscible system. | Q47824414 | ||
| Bioactivity of Epigallocatechin Gallate Nanoemulsions Evaluated in Mice Model. | Q47888794 | ||
| Myricetin solid lipid nanoparticles: Stability assurance from system preparation to site of action. | Q47924454 | ||
| Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery | Q47941756 | ||
| Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption | Q47960609 | ||
| Investigation of itraconazole ternary amorphous solid dispersions based on povidone and Carbopol | Q48000496 | ||
| Engineering hot-melt extruded solid dispersion for controlled release of hydrophilic drugs. | Q48011187 | ||
| Lipid nanoparticles for administration of poorly water soluble neuroactive drugs. | Q48034195 | ||
| Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs | Q48166645 | ||
| Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method | Q48175399 | ||
| Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks. | Q48273811 | ||
| Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. | Q51346958 | ||
| Contribution of formulation and excipients towards enhanced permeation of curcumin. | Q51421139 | ||
| Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies. | Q51630119 | ||
| A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis. | Q51746684 | ||
| Enhancement of dissolution of cyclosporine A using solid dispersions with polyoxyethylene (40) stearate. | Q51933722 | ||
| Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects. | Q52098703 | ||
| In vitro release evaluation of hydrocortisone liquisolid tablets. | Q52240604 | ||
| Powdered solution technology: principles and mechanism. | Q52412639 | ||
| Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism. | Q52769105 | ||
| Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. | Q52779061 | ||
| Preparation of carotenoid extracts and nanoemulsions from Lycium barbarum L. and their effects on growth of HT-29 colon cancer cells. | Q52783586 | ||
| Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. | Q52893748 | ||
| Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material. | Q52911029 | ||
| Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. | Q52930348 | ||
| Poloxamer-based solid dispersions for oral delivery of docetaxel: Differential effects of F68 and P85 on oral docetaxel bioavailability. | Q53106429 | ||
| Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. | Q53212467 | ||
| Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole. | Q53542335 | ||
| Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation. | Q53547529 | ||
| Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. | Q53671539 | ||
| Spray freeze drying as an alternative technique for lyophilization of polymeric and lipid-based nanoparticles. | Q53746037 | ||
| Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study. | Q53841389 | ||
| Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets. | Q54626013 | ||
| Solid Lipid Particles for Oral Delivery of Peptide and Protein Drugs II – The Digestion of Trilaurin Protects Desmopressin from Proteolytic Degradation | Q58199031 | ||
| Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice | Q58479821 | ||
| Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties | Q59089633 | ||
| Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles | Q62128673 | ||
| Dissolution rates of corticosteroids utilizing sugar glass dispersions | Q67563692 | ||
| Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine) | Q80325417 | ||
| Preparation and characterization of emulsified solid dispersions containing docetaxel | Q82798200 | ||
| Carvedilol dissolution improvement by preparation of solid dispersions with porous silica | Q83160331 | ||
| Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles | Q83209539 | ||
| Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance | Q37469233 | ||
| Nanostructured lipid carriers: versatile oral delivery vehicle | Q37474497 | ||
| Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment | Q37702449 | ||
| Liquisolid technology for dissolution rate enhancement or sustained release | Q37781831 | ||
| Drug release from liquisolid systems: speed it up, slow it down | Q37827494 | ||
| Solid lipid nanoparticles: an oral bioavailability enhancer vehicle | Q37914880 | ||
| Supercritical fluid-mediated methods to encapsulate drugs: recent advances and new opportunities. | Q38029654 | ||
| Pharmaceutical cocrystals and poorly soluble drugs. | Q38064634 | ||
| Lipid-based formulations for oral administration of poorly water-soluble drugs | Q38098332 | ||
| Nanotechnology versus other techniques in improving drug dissolution | Q38104803 | ||
| Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance. | Q38115195 | ||
| Recent advancements in mechanical reduction methods: particulate systems | Q38132471 | ||
| Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs | Q38140539 | ||
| Liquisolid systems and aspects influencing their research and development. | Q38180830 | ||
| Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis | Q38218602 | ||
| Self emulsifying drug delivery system (SEDDS) for phytoconstituents: a review | Q38261828 | ||
| Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques | Q38411322 | ||
| Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug/cyclodextrin complexes | Q38522903 | ||
| Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review | Q38573948 | ||
| Nanocrystals: From Raw Material to the Final Formulated Oral Dosage Form--A Review | Q38577395 | ||
| Liquisolid technology: What it can do for NSAIDs delivery? | Q38591550 | ||
| Preparation, characterization and bioavailability by oral administration of O/W curcumin nanoemulsions stabilized with lysophosphatidylcholine | Q38601227 | ||
| Downstream processing from hot-melt extrusion towards tablets: A quality by design approach | Q38617036 | ||
| Potential of Liposomes for Enhancement of Oral Drug Absorption. | Q38697012 | ||
| Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption | Q38737248 | ||
| Improved delivery of poorly soluble compounds using nanoparticle technology: a review | Q38739589 | ||
| Photoresponsive lipid-polymer hybrid nanoparticles for controlled doxorubicin release | Q38754743 | ||
| Quercetin-Loaded Solid Lipid Nanoparticle Dispersion with Improved Physicochemical Properties and Cellular Uptake | Q38760416 | ||
| Polymeric mixed micelles as nanomedicines: Achievements and perspectives | Q38770572 | ||
| Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines | Q38776000 | ||
| Utilization of nanoemulsions to enhance bioactivity of pharmaceuticals, supplements, and nutraceuticals: Nanoemulsion delivery systems and nanoemulsion excipient systems. | Q38777505 | ||
| Physical chemistry of supersaturated solutions and implications for oral absorption. | Q38788184 | ||
| Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide | Q38790254 | ||
| Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions | Q38790753 | ||
| Formulation and in vitro efficacy of liposomes containing the Hsp90 inhibitor 6BrCaQ in prostate cancer cells. | Q38807397 | ||
| Bioimaging of nanoparticles: the crucial role of discriminating nanoparticles from free probes | Q38808416 | ||
| 50years of oral lipid-based formulations: Provenance, progress and future perspectives | Q38811050 | ||
| Development of "all natural" layer-by-layer redispersible solid lipid nanoparticles by nano spray drying technology. | Q38836577 | ||
| The impact of formulation attributes and process parameters on black seed oil loaded liposomes and their performance in animal models of analgesia. | Q38875216 | ||
| Oral bioavailability enhancement through supersaturation: an update and meta-analysis. | Q38917369 | ||
| Comparison of drug release from liquid crystalline monoolein dispersions and solid lipid nanoparticles using a flow cytometric technique | Q38950475 | ||
| Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique | Q38958062 | ||
| PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. | Q38976681 | ||
| Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells | Q38981114 | ||
| Phytosomes as Biocompatible Carriers of Natural Drugs | Q38996565 | ||
| Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. | Q39032959 | ||
| BCS class IV drugs: Highly notorious candidates for formulation development | Q39088924 | ||
| Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration | Q39131775 | ||
| Cellular uptake and antitumour activity of paclitaxel incorporated into trilaurin-based solid lipid nanoparticles in ovarian cancer | Q39164588 | ||
| Phospholipid Complex Technique for Superior Bioavailability of Phytoconstituents | Q39308835 | ||
| Novel strategies for the formulation and processing of poorly water-soluble drugs | Q39322994 | ||
| Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry. | Q39472028 | ||
| An investigation on the solid dispersions of chlordiazepoxide | Q39526624 | ||
| Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying | Q39910750 | ||
| Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers | Q40585993 | ||
| Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers. | Q40723013 | ||
| Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs | Q40851361 | ||
| Improved Antitumor Efficacy of Hyaluronic Acid-Complexed Paclitaxel Nanoemulsions in Treating Non-Small Cell Lung Cancer | Q40951484 | ||
| Magnetic Nanoemulsions: Comparison between Nanoemulsions Formed by Ultrasonication and by Spontaneous Emulsification. | Q41175907 | ||
| Liquisolid systems to improve the dissolution of furosemide | Q41182158 | ||
| Effect of hydrogen bond formation/replacement on solubility characteristics, gastric permeation and pharmacokinetics of curcumin by application of powder solution technology | Q41512316 | ||
| Efavirenz Self-Nano-Emulsifying Drug Delivery System: In Vitro and In Vivo Evaluation | Q41599923 | ||
| Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin | Q41844498 | ||
| Design and Characterization of Buccoadhesive Liquisolid System of an Antihypertensive Drug | Q41982108 | ||
| Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability | Q41987423 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioavailability | Q461809 |
| P304 | page(s) | 74 | |
| P577 | publication date | 2018-06-23 | |
| P1433 | published in | Pharmaceutics | Q27723332 |
| P1476 | title | Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs | |
| P478 | volume | 10 |
| Q89598052 | Anticancer Activity of Rutin and Its Combination with Ionic Liquids on Renal Cells |
| Q90558506 | Assessing the risk of drug crystallization in vivo |
| Q92861525 | Cholate-modified polymer-lipid hybrid nanoparticles for oral delivery of quercetin to potentiate the antileukemic effect |
| Q60948805 | Choline-Amino Acid Ionic Liquids as Green Functional Excipients to Enhance Drug Solubility |
| Q57061490 | Development of an Oral Compound Pickering Emulsion Composed of Nanocrystals of Poorly Soluble Ingredient and Volatile Oils from Traditional Chinese Medicine |
| Q93081305 | Effect of Primary and Secondary Beads of Carbon Enterosorbent on Haematological Parameters and Oxidative Stress Development Caused by Melphalan in Rats |
| Q92783360 | Long-Term Physical (In)Stability of Spray-Dried Amorphous Drugs: Relationship with Glass-Forming Ability and Physicochemical Properties |
| Q92944968 | Solubility Studies of Cyclosporine Using Ionic Liquids |
| Q90310800 | Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs |
| Q90233127 | The Effects of Vinegar Processing on the Changes in the Physical Properties of Frankincense Related to the Absorption of the Main Boswellic Acids |
| Q64992491 | The Process⁻Property⁻Performance Relationship of Medicated Nanoparticles Prepared by Modified Coaxial Electrospraying. |
Search more.